Digirad, a diagnostic imaging system developer, has received FDA 510(k) marketing clearance for its new nSPEED reconstruction software.

The Poway, Calif.-based company said that with nSPEED its Digirad Cardius solid-state dedicated cardiac systems can perform cardiac SPECT imaging procedures in as little as three minutes or with one-half the required pharmaceutical dosages.

Digirad said the reconstruction software can be used in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and non-parallel hole collimators.